Early Warning Early Action

IscAlert™ is a biomedical sensor that measures partial gas pressure of carbon dioxide (pCO2) in tissue and is intended for the purpose of indicating the perfusion status of the muscle, subcutaneous tissue, connective tissue, or mucosal membranes local to sensor placement.

The tissue pCO2 is a parameter which increases significantly during the early and reversible stages of ischemia. Monitoring of local tissue pCO2 provides the ability to identify the onset of ischemic events before irreversible injury occurs.

Ischemia is the medical term for shortage of blood supply to an organ or tissue, typically caused by the narrowing or obstruction of arteries or veins.

The IscAlert sensor is a single-use surgically invasive sensor, intended for short-term use (up to 14 days).

IscAlert effectively monitors ischemic conditions in muscle, subcutaneous tissue, connective tissue, and mucous membranes.

Ischemic conditions in these tissues can lead to irreversible damage, such as muscle atrophy, loss of skin integrity, necrosis of soft tissues, and impaired wound healing.

These effects can significantly compromise the functionality and health of the affected areas.

There is a great medical need to be able to measure in real time whether tissues are getting enough blood supply. Insufficient blood supply is a common cause of illness and death, and can cause complications after operations
— Tor Inge Tønnessen, Professor of Anesthesiology and Intensive Care, Oslo University Hospital and Founder of Sensocure AS

Cooperation

The development of IscAlert is supported by